CBD Oil and Paleo/Keto Diets: Research and What You Should Know
CBD (cannabidiol) is a cannabinoid found in marijuana, but it doesn’t have any psychoactive effects (in other words, it doesn’t cause a high). The cannabinoid in marijuana that causes a high is THC (tetrahydrocannabinol), not CBD.
Recently, there’s been a huge surge of interest in the health benefits of CBD and a predictable increase in the number of products with CBD added to them: on top of the basic CBD oil, there’s a whole range of eatable and drinkable CBD products from fizzy soft drinks to lattes to brownies. CBD is more acceptable than THC-containing products to people who can’t or don’t want to get high, and there’s some interesting evidence that it may help with pain, anxiety/depression, and possibly insomnia.
If you believe all the marketing hype, CBD is the new elixir of life, but as usual, the marketing is way overhyped. Here’s a look at the actual research, but first…
Is this stuff even legal?
As this post explains, it’s complicated. In the US, CBD isn’t considered a dietary supplement and it isn’t regulated like normal supplements. The legal status of CBD depends on whether your particular state has legalized recreational and/or medical marijuana use, and possibly on whether the CBD in question is extracted from marijuana or industrial hemp. 17 states also have laws specific to CBD. Here’s a map showing which states have what kinds of laws, with details available for each state.
The federal government still considers marijuana-derived CBD to be illegal (although some CBD sellers have argued that this doesn’t technically apply to hemp-derived CBD), but in practice, enforcement is patchy at best and CBD is pretty widely available, especially online. Here is a research paper breaking it down in extreme detail, for the curious. In short, it’s very hard to say and trying to figure out the relevant laws is a recipe for a headache: here’s to hoping that we get some clarity on this soon.
Is it safe?
This review looked at precisely that question and concluded that it probably is. The researchers found that CBD is mostly safe and definitely safer than a lot of common psychiatric medications. When people had side effects, the most common reported problems were fatigue, diarrhea, and changes in weight and appetite – none of those are fun, but none of them are really deadly. But the authors also noted that:
“some important toxicological parameters are yet to be studied, for example, if CBD has an effect on hormones. Additionally, more clinical trials with a greater number of participants and longer chronic CBD administration are still lacking.”
A bigger problem for a lot of interested consumers is that the CBD market is barely regulated, so it can be really hard to find products that actually contain the advertised amounts of CBD. A 2018 study found that many commercially available CBD products didn’t contain the amount of CBD advertised on the label. One study found that only 30% of CBD products were accurately labeled to reflect the amount of CBD they actually contained (26% contained less CBD than they claimed; 43% contained more than they claimed). Even more concerningly, the study found that nearly 20% of products sold as pure CBD actually contain at least some THC (that’s the chemical in marijuana that does get you high).
This is all important for anyone thinking of trying CBD to consider: when you buy a supplement, you ought to feel confident you’re getting the label ingredients and nothing else, but that’s just not the case with a lot of CBD products.
Does it work? Evidence in humans
Based on evidence that it’s helpful, the FDA has approved an oral formulation of CBD as a treatment for drug-resistant epilepsy in children. CBD is also approved in Canada to treat pain from multiple sclerosis. But most people who walk into a CBD store aren’t children with epilepsy or MS patients: what about the rest of us?
A couple of studies have examined CBD oil for pain in humans, particularly chronic pain. For example, This review of reviews concluded that some reviews found evidence of benefits for multiple sclerosis (MS) pain and spasticity.
Other studies (here and here) have found benefits of CBD for cancer pain specifically. And in this study of 303 patients with allodynia (that’s a problem where you weirdly feel pain from things that shouldn’t hurt), a combined THC/CBD spray was safe and effective, even in patients who didn’t respond to other painkillers.
This study found that CBD definitely doesn’t mess with normal sleep patterns and suggested that it might be helpful for restoring altered sleep patterns.
Brain health/mental health
On top of being FDA-approved for treating epilepsy, this review of human studies explains how CBD may have some antipsychotic properties, but the conclusion highlights the need for way more big, high-quality studies before anyone starts claiming anything about it for sure.
This review of CBD for mental health and psychiatric issues also stresses the call for more research – the authors found a little bit of evidence for treating symptoms of social anxiety and schizophrenia, but noted that “most of the studies published presented several drawbacks and did not reach statistical significance.”
This review, specifically on anxiety, also noted that the human studies so far are all on acute administration (you give someone CBD once and see how they feel), not chronic administration (you give someone CBD every day for three weeks and see how they feel), which is another huge gap in the research.
This aspect of CBD just doesn’t enough research to draw clear conclusions in humans, although it would be really great to find out that there’s actually a benefit.
Two more miscellaneous items to round off the list:
- This review found five human studies suggesting that CBD may be helpful for people trying to quit smoking cigarettes.
- This study is also fascinating: unlike THC, CBD (16 mg, delivered via inhaler) actually improved subjects’ ability to recognize facial expressions and match them to emotions.
What do actual CBD users say?
Finally, there’s this survey. The researchers in this study didn’t actually give CBD to anyone. Instead, they asked current CBD users why they use it. Of course, this is only surveying people who liked CBD enough to stick with it, so it’s biased towards people who had a good experience with CBD.
About two-thirds of those people said they used CBD for medical reasons, with the most common reasons being chronic pain, arthritis/joint pain, anxiety, depression, and insomnia. Just over a third of respondents claimed that CBD worked “very well” to address their problem. About one third also reported some kind of minor side effect. The most common side effects were dry mouth (11% of people), euphoria (6.43%), hunger (6.35%), and red eyes (2.74%).
Again, this isn’t a super rigorous test of efficacy, but it’s interesting in the absence of big clinical trials on some of these things.
Does it work? Evidence in animals
Predictably, there’s more of it and it looks pretty neat.
For example, animal studies have found that CBD relieves pain and inflammation in a variety of contexts. Here’s a study on eye pain in mice; here’s one on arthritis pain and inflammation in rats that improved after rubbing CBD oil directly on the affected areas. This study also found that CBD reduced the inflammation and immune dysfunction involved in fatty liver disease in rats
Animal research on the mental health/brain health benefits of CBD also looks promising. For example, this study found that oral CBD helped alleviate depressive symptoms in rats genetically prone to depression and this one found some interesting fast-acting antidepressive benefits. A review of cannabis and cannabinoids in sleep disorders found that CBD alleviated insomnia in animal models, but studies in humans are still really limited.
This type of animal research is where a lot of claims about the benefits of CBD come from, but animal research doesn’t necessarily translate into human benefits.
CBD and Paleo or Keto
None of these studies examined the combination of CBD oil and diet, although the potential anti-inflammatory effects definitely seem to complement a Paleo-style approach to health.
One major worry, especially for the low-carbers, might be “will CBD give me the munchies?” – but fortunately, this study found that low doses of CBD didn’t cause sweet cravings or increase liking of sweet foods.
From a Paleo perspective, CBD oil also comes under scrutiny for fat quality – and that goes double for any kind of CBD candy, CBD cookies, CBD drinks, and other edibles. But other than that, the studies above suggest that it’s compatible with a Paleo diet and lifestyle habits – like any other supplement, the question is really whether it’s right for you and whether you have a clear reason to be taking it. The Paleo approach isn’t about out-supplementing a bad diet, but there’s definitely a role for a few carefully-chosen supplements to complement a base diet of nutrient-dense whole foods.
So what does it all mean?
Ultimately, these studies suggest that the biggest risk of taking CBD might not be the CBD itself but rather the chance of getting a contaminated supplement or one that’s inaccurately labeled (causing you to take more or less than you think you’re taking). There’s also the question of legal status, which is incredibly unclear and confusing in most places.
It’s also true that the evidence doesn’t support the really extreme claims about CBD, like the idea that it prevents/cures cancer or that it’s some magical therapy for chronic pain in all patients. But it’s definitely an interesting one to watch and it’ll be cool to see what happens as more and more human studies start coming out.
Have a look at Paleo Restart, our 30-day program. It has the tools to let you reset your body, lose weight and start feeling great. Learn more and get started here.
+ #PaleoIRL, our new cookbook all about making Paleo work for a busy life is now available! Get it now here.
CBD oil: what is it, why is it suddenly everywhere, and is it compatible with a keto or Paleo diet? Here's a look at some of the research.
Habitual Marijuana Use and the Paleo Diet: What a Long Strange Trip it’s Been
Last month I had the pleasure to lecture on the Paleo Diet in Sydney, Australia at the BioCeuticals Research Symposium. After my presentation a couple who appeared to be in their late 40s to early 50s approached the podium. The man and his wife told me they had adopted the Paleo Diet a few years back and wondered if habitual marijuana smoking was aligned with Paleo. Both indicated they had been regular pot smokers for decades since their college undergraduate days. As I previously pointed out, humans have only recently (from an evolutionary perspective) acquired the technological sophistication to start fires at will. On a 24 hour clock representing the entire 2.5 million year Paleolithic era, humanity’s ability to create fire first came into regular play somewhere between 48 and 36 minutes to midnight. Need I say more?
I am a child of the ’60s. I came of age in southern California and northern Nevada when political, social and recreational drug standards were radically changing for many young people nationwide and for the US society as a whole. In high school and college during the ’60s and early ’70s, “the day,” I participated on various athletic teams that required regular aerobic workouts, almost year round. Consequently, smoking anything (tobacco or dope) was completely out of the question for me. very summer from my early 20s until I was 42, I worked as the Head Lifeguard on a major beach at Lake Tahoe, so my former aerobic workout ethic continued with me throughout my later life.
An almost universally accepted narcotic of “the day” was marijuana, dope or pot. Call it whatever you will, but this drug became emblematic of the “youth generation” who grew up during the ’60s and early ’70s. My generation is now approaching our retirement years, yet the legacy our age group created regarding recreational drug use lives on. So much so, that my generation and our children’s generation and our grand children’s generation have recently voted to legalize marijuana for recreational use in Colorado and Washington state. Additionally, if we look at national response to recreational drug use a little more than half the country’s voters favor marijuana’s legalization.
Nevertheless, marijuana has not been legally sanctioned for recreational use in the 48 other states, and remains the most widely used illicit drug in the US (16.7 million users during the past month). 1 The more important point of this statistic is that about 283 million Americans did not use marijuana in the past month. President Clinton claimed he never “inhaled” when smoking pot as a college student, whereas President Obama freely admitted to its use in his earlier years. Accordingly, marijuana is a drug which many if not most Americans have experimented with, particularly during their youth. Currently 43% of all high school seniors have tried pot, 2 and as many of you may have personally witnessed, marijuana is the most commonly used illicit drug on college campuses. 3
In my blog and scientific writings, I can honestly say that I have never deliberately ventured into political or social commentary – and sorry – you won’t get that perspective here either. However, I would like to remark upon the physiological ramifications of regular pot smoking or ingestion upon your health and well being. All plant compounds (either smoked or ingested) entering our bodies on a regular basis, just like any other nutritional or dietary element, will have an effect upon our overall health. So, you be the judge, and let the data below speak for itself. In the final analysis, you (the learned reader) must decide the ultimate route that you will take for your health and well being and that of your family.
You don’t have to be a scientist to understand why people smoke or ingest marijuana. For most people it produces a pleasurable “high” or euphoria. Most marijuana users know that the primary active compound in pot which elicits this narcotic drug’s high is delta-9-tetrahydrocannabinol (THC). However, few pot smokers are aware that marijuana also contains over 60 related compounds called cannabinoids and more than 400 other chemicals including benzopyrene, a well recognized carcinogen. 4
When marijuana is smoked, THC quickly passes from the lungs to the bloodstream which then transports THC to the brain and all other organs of the body. Consumption of marijuana laced cookies, brownies or candies takes longer for the high to occur because marijuana must first be digested in the gastrointestinal tract and then absorbed before THC reaches the bloodstream. Whether pot is smoked or ingested, once THC reaches the brain it binds to specific molecular sites called cannabinoid receptors which in turn set off a series of biochemical reactions resulting in the high that users experience. 4 The greatest density of cannabinoid receptors occurs in areas of the brain that influence pleasure, memory, coordination, thinking, concentration and sensory and time perception. 5
Predictably, acute THC intoxication is associated with impairment of cognitive function including: learning and memory, attention span, planning ability, organizational skills, problem solving, decision making, perception of facts, control of emotions and behavior 2, 4, 6, 7 and impairment of motor coordination. 2, 7, 8 Perhaps that’s why even states like Colorado and Washington, which have legalized recreational marijuana use, still impose strict legal penalties for driving while high on pot, similar to the consequences of driving under the influence of alcohol. Two recent meta analyses (large, pooled, population studies) concluded that: “Acute cannabis consumption is associated with an increased risk of a motor vehicle crash, especially for fatal collisions,” 9 and “The results of this meta-analysis suggest that marijuana use by drivers is associated with a significantly increased risk of being involved in motor vehicle crashes.” 10
OK – so get stoned, but just don’t drive while you are high and nobody is hurt, including yourself – but are you really? Are the effects of acute marijuana use only transitory or are there chronic, long-term effects of dope smoking which may adversely affect your health?
These potentially undesirable effects would be robustly predicted by the evolutionary medicine model: 1) introduce an evolutionarily novel agent into an organism’s physiology that has been conditioned over eons of natural selection without it; 2) if the novel agent produces evolutionary discordance between the organism’s genes and its environment, then 3) this discordance elicits increased morbidity (disease incidence), mortality (death) and reduced reproductive success. My mentor, Boyd Eaton coined the term, evolutionary discordance, 11 but it was Charles Darwin who first conceived of the most powerful idea in all of biology. Hence, evolution via natural selection is the organizational template for contemporary Paleo diets. This concept represents the evolutionary logic underlying the adverse health effects produced by recently introduced food staples (refined sugars, trans fats, vegetable oils, cereal grains, dairy products, salt and processed foods).
Why should recently introduced narcotic drugs affect our health in an evolutionary manner that varies fundamentally from recently introduced foods? Both items represent novel environmental factors in which our physiology and biochemical pathways have had little evolutionary experience to adapt to and both would be expected to cause evolutionary discordance, which in turn elicits increased morbidity and mortality and hence reduced reproductive success. Natural selection then may respond to these changing environmental selective pressures by moving the organism’s genome to a new set point, frequently resulting in a new species, or alternatively the species may become extinct.
Very few scientists studying narcotic drugs would argue that acute marijuana intoxication either via ingestion or smoking does not temporarily impair cognitive function in a variety of ways. The human experimental and epidemiological data outlined above is forceful, compelling and undeniable. 2, 4, 6, 7, 8 Less clear are the long-term behavioral and psychological changes which may occur from chronic marijuana use. Nevertheless a number of recent human meta-analyses support the notion that long term pot smoking fundamentally re-arranges brain structure in a manner that may in turn adversely influence cognitive function.
In a recent meta-analysis Rocchetti and colleagues reviewed 14 MRI studies examining how smoked marijuana affected the brains of healthy people without psychotic illness. 12 “Our meta-analysis showed a consistently smaller hippocampus in users as compared to non-users. Our results suggest that in the healthy brain, chronic and long-term cannabis exposure may exert significant effects in brain areas enriched with cannabinoid receptors, such as the hippocampus, which could be related to a neurotoxic action.”
From this study, it cannot be determined if reductions in brain hippocampus size in pot smokers influences behavior or psychological factors on a long term basis.
Similar, but not as robust, results were reported in a meta-analysis by Dr. Lorenzetti and co-workers at the University of Melbourne. 13 They concluded that, “Together, these structural imaging findings suggest that THC exposure does affect brain morphology, especially in medial-temporal regions.” Three years later in 2013 after reviewing the most recent literature, 14 Dr. Lorenzetti’s research group came to a comparable conclusion: “This review supports the notion that regular cannabis use is associated with alterations of brain morphology.” In a larger, recent meta-analysis involving both adults and adolescents, similar observations and conclusions were reached by yet another independent research group. 15
An early study 16 by Dr. Lorenzetti and colleagues, that concurrently measured brain hippocampal and amygdala volumes along with verbal learning ability and psychotic symptoms, concluded, “These results provide new evidence of exposure-related structural abnormalities in the hippocampus and amygdala in long-term heavy cannabis users and corroborate similar findings in the animal literature. These findings indicate that heavy daily cannabis use across protracted periods exerts harmful effects on brain tissue and mental health.”
One of the factors in this study which may not apply to casual pot smokers was that the subjects were “heavy” users, consuming more than five joints daily for more than 10 years. Clearly, these subjects maintained pot addictions that are not necessarily representative of recreational marijuana smokers.
Nevertheless, a just released cross sectional study in young, recreational, non-dependent, marijuana users revealed disruptions of normal anatomical brain structure in the amygdala and nucleus accumbens when compared to non users (17). The shortcomings of this experiment and most other studies evaluating brain structural and functional changes in marijuana smokers is that they are cross sectional in nature – meaning that they view results at a single point in time. What are needed are experimental studies (randomized controlled trials [RCTs]) which randomly assign subjects to pot smoking and control groups and then compare pre-post intervention differences. RCT’s on pot smoking will provide us with the definitive data we need to make informed decisions about marijuana’s chronic effects upon brain function and mental health.
When scientists do literature reviews on almost any topic, not all papers are in perfect agreement with one another and frequently yield vastly differing results and conclusions for a variety of reasons, usually involving experimental methodology. Hence to the casual reader of the scientific literature it is almost always possible to find a paper or two that conforms to your particular bias, but invariably you can also find a few which are inconsistent with your preconception. To overcome this potential prejudice, scientists have developed procedures which allow them to pool any and all individual experiments on a topic and statistically analyze the entire collective group as if it were one. This technique is called a meta-analysis, and represents a powerful statistical tool to make sense out of multiple studies with conflicting results. Notice that almost all studies I have cited previously regarding marijuana’s adverse effects upon brain structure or function are either meta-analyses, or comprehensive reviews.
Now let’s take a look at how pot smoking may adversely influence the mind, or our perceptions of reality. “Psychoses” is a generic term referring to multiple abnormal mental conditions which frequently are characterized by “a loss of contact with reality.” You have probably heard of some of these psychoses which include: hallucinations, delusional beliefs [some may be paranoid], schizophrenia, severe depression, bipolar disorder (manic depression) and others.
The studies of marijuana use and psychoses below are all meta-analyses, and I have quoted the conclusion of each of these studies:
- “The results suggest that the association between cannabis use and earlier onset of psychosis is robust and is not the result either of tobacco smoking by cannabis using patients or the other potentially confounding factors we examined. This supports the hypothesis that, in some patients, cannabis use plays a causal role in the development of schizophrenia and raises the possibility of treating schizophrenia with new pharmacological treatments that have an affinity for endo-cannabinoid receptors.” 18
- “The results of meta-analysis provide evidence for a relationship between cannabis use and earlier onset of psychotic illness, and they support the hypothesis that cannabis use plays a causal role in the development of psychosis in some patients. The results suggest the need for renewed warnings about the potentially harmful effects of cannabis.” 19
- “Approximately every fourth schizophrenia patient in our sample of studies had a diagnosis of CUDs (cannabis use disorders). CUDs were especially common in younger and first-episode patient samples as well as in samples with a high proportion of males.” 20
- “The objective of this article was to examine whether cannabis use can be an independent risk factor for chronic psychotic disorders, by using established criteria of causality. Data extracted from the selected studies showed that cannabis use may be an independent risk factor for the development of psychotic disorders. Early screening of the vulnerability to psychotic disorder should permit improved focus on prevention and information about the specific risks related to cannabis use among this population.” 21
- “On the basis of cohort studies that have been conducted within the last decades and recent meta-analyses the hypothesized connection between cannabis use and psychotic disorders can be corroborated. The risk to develop psychotic symptoms and also schizophrenic psychoses is thus explicitly elevated for young people who use cannabis.” 22
- “The evidence is consistent with the view that cannabis increases risk of psychotic outcomes independently of confounding and transient intoxication effects, although evidence for affective outcomes is less strong. The uncertainty about whether cannabis causes psychosis is unlikely to be resolved by further longitudinal studies such as those reviewed here. However, we conclude that there is now sufficient evidence to warn young people that using cannabis could increase their risk of developing a psychotic illness later in life.” 23
- “Early use of cannabis did appear to increase the risk of psychosis. For psychotic symptoms, a dose-related effect of cannabis use was seen, with vulnerable groups including individuals who used cannabis during adolescence, those who had previously experienced psychotic symptoms, and those at high genetic risk of developing schizophrenia. In conclusion, the available evidence supports the hypothesis that cannabis is an independent risk factor, both for psychosis and the development of psychotic symptoms. Addressing cannabis use, particularly in vulnerable populations, is likely to have beneficial effects on psychiatric morbidity.” 24
- “Cannabis use, and particularly heavy cannabis use, may be associated with an increased risk for developing depressive disorders. There is need for further longitudinal exploration of the association between cannabis use and developing depression, particularly taking into account cumulative exposure to cannabis and potentially significant confounding factors.” 25
Physiologic and Health Effects
The mental, behavioral and psychological effects of marijuana use have received much interest in the scientific community over the past 20-30 years, however an equally important and nearly as extensive scientific literature exists regarding marijuana’s effects upon other body organs, systems and tissues.
Lung and respiratory function
For the past 40 years of my life, I have had the luxury of spending part of my summers on Lake Tahoe’s pristine east shore. The high, alpine air here at 6,300 ft above sea level is nothing short of exhilarating and filled with therapeutic negative ions naturally generated near waterfalls and crashing waves. Each summer when I first arrive, I take in a deep breath of this magical elixir and contemplate Mark Twain’s famous quote, “Three months of camp life on Lake Tahoe would restore an Egyptian mummy to his pristine vigor.”
One unfortunate summer a number of years ago, northern California and Nevada had one of the worst wildfire seasons on record. The entire Tahoe basin was filled with smoke – our eyes reddened and watered, we coughed incessantly, our heads hurt and the alpine magic that once was, no longer existed. To my way of thinking I can’t imagine how anyone would ever intentionally put their lungs and respiratory system into a smoky forest fire environment on a regular basis – yet that is exactly what pot smokers do.
Incinerated and inhaled marijuana, like tobacco contains a toxic combination of gases and other chemicals that can be injurious to the lungs and respiratory system. 26 The most recent reviews of habitual incinerated marijuana inhalation have concluded that it increases cough, sputum production, upper lung emphysematous changes, chronic bronchitis, and large airway inflammation. 27-29 Whether or not pot smoking initiates or promotes lung cancer has remained controversial 4, 27, 28 partially because few adequately powered (statistically), prospective epidemiological studies have ever been conducted. Recently, just such a study has been published in which “heavy” marijuana smokers (lifetime use of more than 50 joints) were followed for a 40 year period. 30 The results of the study showed a more than twofold risk of developing lung cancer even after statistical adjustment for tobacco and alcohol use.
In healthy, young adults the risk for fatal or serious health threatening events from cardiovascular disease (CVD) is low to non-existent, yet the medical literature reveals case study after case study of young marijuana smokers showing increased morbidity (disease incidence) from CVD and even fatal CVD events attributable to marijuana use. 31-38 Older pot smokers are also at an increased risk for CVD events including myocardial infarctions (heart attacks), sudden cardiac death, cardiomyopathy, stroke, transient ischemic attack, atrial fibrillation and arteritis. 4, 39-41
Sports and athletic function
If you aspire to be a national or international caliber athlete, smoking pot is definitely something you don’t want to do. Whether you are an Olympic, professional or college level athlete, you can be randomly tested for illicit drug use including marijuana. Testing positive can potentially ruin your athletic career from the sport’s regulatory bodies and/or legal fallout. Marijuana has been on the International Olympic Committee’s list of prohibited drugs since 1989.
More importantly, acute marijuana use reduces maximal exercise test duration and increases sub-maximal exercise heart rates. 4, 42 Both of these changes will impair acute aerobic exercise performance. The available evidence 43 suggests that habitual dope smoking will impair exercise training, which in turn will impair performance on race day.
A recent paper 44 which compiled the results of 122 studies and 446 references concluded that, “endocannabinoids (the body’s naturally produced cannabinoids) enhanced immune response, whereas exogenous cannabinoids (marijuana) had immune-suppressant effects.” It has been previously suggested that immune system impairment by marijuana use may increase infectious disease susceptibility. 45 Taken together, this information suggests that habitual pot smoking likely increases the incidence of the common cold and its severity in a manner similar to smoking tobacco. 46 For athletes, the greater the incidence and severity of the common cold, the greater your training intensity will be reduced, which in turn will reduce your performance on race day. 47
Dental and Oral Health
Habitual dope smokers are apt to have an increased prevalence of dental caries, oral infections, periodontal disease, mouth dryness, leukodemia (blue, grey or white appearance on the mouth’s inside cheeks) and an increased prevalence of the fungus Candida albicans than non-smokers. 4, 48, 49 To say nothing of their foul breath.
If you are pregnant or nursing and regularly smoke pot, whether you know it or not, your unborn fetus or dependent nursing infant is also getting high with you, even if you are not high when you nurse. As a regular marijuana smoker, the primary psychoactive ingredient in pot (THC) does not simply exit your body like alcohol after a few hours or a few days, but remains in your system for 10-30 days because it is stored in your body fat. 4 This fact allows potential employers to screen your urine for past marijuana use, and furnishes your baby/fetus with THC whether or not you are acutely smoking pot or not. OK – no big deal, you are unemployed and your urine will not be screened. What about your baby? Do you want this beautiful boy or girl to also participate in your marijuana addiction?
A recent and comprehensive review of marijuana, the pregnant woman and her child has this to say, “Current evidence indicates that cannabis use both during pregnancy and lactation, may adversely affect neurodevelopment, especially during periods of critical brain growth both in the developing fetal brain and during adolescent maturation, with impacts on neuropsychiatric, behavioural and executive functioning. These reported effects may influence future adult productivity and lifetime outcomes. 50
Perhaps just as important as neurodevelopment is the risk pot smoking places upon a healthy pregnancy and delivery. Marijuana use, even for a short period during pregnancy, increases the risk of adverse birth outcomes including low birth weight, pre-term labor, small gestational age, stillbirth and admission to the neonatal intensive care unit. 51-54
As a couple, whether you realize it or not, your chances of achieving successful fertilization, a normal pregnancy and a healthy infant are dependent not just upon the mother’s health but also upon the father’s. If Mom is a chronic marijuana smoker her chances of a healthy conception are reduced because THC disrupts the normal menstrual cycle, suppresses oogenesis (egg development) and impairs embryo implantation and development. 55, 56 But remember the woman is only one half of the fertility equation, and regular pot smoking by the father is just as risky for conception. THC reduces sperm count and motility, increases ejaculation problems, produces a loss of libido and thereby increasing the risk for impotence. 55-57
It’s bad enough to know that your dope smoking as young parents may have prevented successful conceptions, normal pregnancies and healthy infants, but it adds insult to injury (if you live long enough) to think that your pot addiction during your child’s formative and adolescent years may contribute to their own marijuana/drug addictions. An increasing body of scientific literature indicates that chronic marijuana exposure during the youth and adolescent formative years are related to a range of adverse outcomes in later life, including poorer educational achievement, lower income, unemployment, greater welfare dependence, and reduced life satisfaction (59-63).
Unless you have a medical background, most of you have never heard of the word, hyperemesis, much less cannabinoid hyperemesis. This isn’t surprising as the condition was first described in the medical literature in 2004. 64 This illness is characterized by cyclical vomiting without other identifiable causes in chronic marijuana users. 65-68 Patients with cannabinoid hyperemesis are unresponsive to conventional anti-vomiting drugs and report that compulsive hot baths and showers represent the only reliable treatment to improve symptoms. 66-68 Nevertheless, an obvious cure exists – abstinence. When marijuana use resumes, the condition may recur. 4
I will repeat myself from a passage earlier in this essay. “So, you be the judge, and let the data speak for itself. In the final analysis, you (the learned reader) must decide the ultimate route that you will take for your health and well being and that of your family.”
Loren Cordain, Ph.D., Professor Emeritus
1. Office of Applied Studies, Substance Abuse and Mental Health Services Administration. Office of Applied Studies, US Department of Health and Human Services 2009 Natinal survey on drug use and health, 2009 (ICPSR 26701). Washington, DC: US Department of Health and Human Services.
2. National Institute on Drug Abuse. NIDA InfoFacts: Marijuana, 2009 . www.nida.nih.gov/infofacts/marijuana
3. Mohler-Kuo M, Lee JE, Wechsler H. Trends in marijuana and other illicit drug use among college students: results from 4 Harvard School of Public Health College Alcohol Study surveys: 1993-2001.J Am Coll Health. 2003 Jul-Aug;52(1):17-24.
4. Greydanus DE, Hawver EK, Greydanus MM, Merrick J. Marijuana: Current Concepts.
Front Public Health. 2013 Oct 10;1:42
5. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC.
Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6
6. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):849-63.
7. Crean RD, Crane NA, Mason BJ. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med. 2011 Mar;5(1):1-8. doi: 10.1097/ADM.0b013e31820c23fa.
8. Karila L, Roux P, Rolland B, Benyamina A, Reynaud M, Aubin HJ, Lançon C. Acute and Long-Term Effects of Cannabis Use : A Review. Curr Pharm Des. 2013 Aug 29. [Epub ahead of print]
9. Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012 Feb 9;344:e536. doi: 10.1136/bmj.e536.
10. Li MC, Brady JE, DiMaggio CJ, Lusardi AR, Tzong KY, Li G. Marijuana use and motor vehicle crashes. Epidemiol Rev. 2012 Jan;34(1):65-72.
11. Eaton SB, Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med. 1985 Jan 31;312(5):283-9.
12. Rocchetti M, Crescini A, Borgwardt S, Caverzasi E, Politi P, Atakan Z, Fusar-Poli P. Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users. Psychiatry Clin Neurosci. 2013 Nov;67(7):483-92. doi: 10.1111/pcn.12085. Epub 2013 Sep 30.
13. Lorenzetti V, Lubman DI, Whittle S, Solowij N, Yücel M. Structural MRI findings in long-term cannabis users: what do we know? Subst Use Misuse. 2010 Sep;45(11):1787-808.
14. Lorenzetti V, Solowij N, Fornito A, Lubman D, Yucel M. The Association between Regular Cannabis Exposure and Alterations of Human Brain Morphology: An Updated Review of the Literature. Curr Pharm Des. 2013 Jun 14. [Epub ahead of print]
15. Batalla A, Bhattacharyya S, Yücel M, Fusar-Poli P, Crippa JA, Nogué S, Torrens M, Pujol J, Farré M, Martin-Santos R. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One. 2013;8(2):e55821. doi: 10.1371/journal.pone.0055821. Epub 2013 Feb 4.
16. Lorenzetti V, Lubman DI, Whittle S, Solowij N, Yücel M. Structural MRI findings in long-term cannabis users: what do we know? Subst Use Misuse. 2010 Sep;45(11):1787-808.
17. Gilman JM, Kuster JK, Lee S, Lee MJ, Kim BW, Makris N, van der Kouwe A, Blood AJ, Breiter HC. Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J Neurosci. 2014 Apr 16;34(16):5529-38. doi: 10.1523/JNEUROSCI.4745-13.2014.
18. Myles N, Newall H, Nielssen O, Large M. The association between cannabis use and earlier age at onset of schizophrenia and other psychoses: meta-analysis of possible confounding factors. Curr Pharm Des. 2012;18(32):5055-69
19. Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry. 2011 Jun;68(6):555-61
20. Koskinen J, Löhönen J, Koponen H, Isohanni M, Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull. 2010 Nov;36(6):1115-30
21. Le Bec PY, Fatséas M, Denis C, Lavie E, Auriacombe M. [Cannabis and psychosis: search of a causal link through a critical and systematic review]. Encephale. 2009 Sep;35(4):377-85.
22. Kawohl W, Rössler W. Cannabis and Schizophrenia: new findings in an old debate].
23. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G.
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007 Jul 28;370(9584):319-28
24. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol. 2005 Mar;19(2):187-94.
25. Lev-Ran S, Roerecke M, Le Foll B, George TP, McKenzie K, Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med. 2014 Mar;44(4):797-810
26. Tashkin DP. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med. 2001 Mar;7(2):43-61.
27. Owen KP, Sutter ME, Albertson TE. Marijuana: respiratory tract effects. Clin Rev Allergy Immunol. 2014 Feb;46(1):65-81
28. Joshi M, Joshi A, Bartter T Marijuana and lung diseases. Curr Opin Pulm Med. 2014 Mar;20(2):173-9
29. Tashkin DP, Simmons MS, Tseng CH. Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis. COPD. 2012 Aug;9(4):367-74.
30. Callaghan RC, Allebeck P, Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control. 2013 Oct;24(10):1811-20
31. Jouanjus E, Lapeyre-Mestre M, Micallef J; French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications*.
Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014 Apr 23;3(2):e000638. doi: 10.1161/JAHA.113.000638
32. Leblanc A, Tirel-Badets A, Paleiron N, Castellant P, Cornily JC, Andre M, Grassin F, Feuvrier Y, Blanchard C, Zagnoli F, Quiniou G, Vinsonneau U. Cannabis and myocardial infarction without angiographic stenosis in young patient: guilty or not guilty? A case report].
Ann Cardiol Angeiol (Paris). 2011 Jun;60(3):154-8
33. Bailly C, Merceron O, Hammoudi N, Dorent R, Michel PL. Cannabis induced acute coronary syndrome in a young female.Int J Cardiol. 2010 Aug 6;143(1):e4-6. doi: 10.1016/j.ijcard.2008.11.200. Epub 2009 Jan 27.
34. Kocabay G, Yildiz M, Duran NE, Ozkan M. Acute inferior myocardial infarction due to cannabis smoking in a young man. J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):669-70.
35. Basnet S, Mander G, Nicolas R. Coronary vasospasm in an adolescent resulting from marijuana use. Pediatr Cardiol. 2009 May;30(4):543-5. doi: 10.1007/s00246-009-9384-7. Epub 2009 Feb 11.
36. Dwivedi S, Kumar V, Aggarwal A. Cannabis smoking and acute coronary syndrome: two illustrative cases. Int J Cardiol. 2008 Aug 18;128(2):e54-7. Epub 2007 Aug 17.
37. Tatli E, Yilmaztepe M, Altun G, Altun A. Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man. Int J Cardiol. 2007 Sep 3;120(3):420-2. Epub 2006 Nov 9.
38. Lindsay AC, Foale RA, Warren O, Henry JA. Cannabis as a precipitant of cardiovascular emergencies. Int J Cardiol. 2005 Sep 30;104(2):230-2.
39. Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol. 2014 Jan 1;113(1):187-90.
40. Korantzopoulos P, Liu T, Papaioannides D, Li G, Goudevenos JA. Atrial fibrillation and marijuana smoking. Int J Clin Pract. 2008 Feb;62(2):308-13
41. Peyrot I, Garsaud AM, Saint-Cyr I, Quitman O, Sanchez B, Quist D. Cannabis arteritis: a new case report and a review of literature. J Eur Acad Dermatol Venereol. 2007 Mar;21(3):388-91.
42. Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol. 2002 Nov;42(11 Suppl):64S-70S.
43. Pesta DH, Angadi SS, Burtscher M, Roberts CK. The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance. Nutr Metab (Lond). 2013 Dec 13;10(1):71. doi: 10.1186/1743-7075-10-71.
44. Suárez-Pinilla P, López-Gil J, Crespo-Facorro B. Immune system: A possible nexus between cannabinoids and psychosis. Brain Behav Immun. 2014 Feb 7. pii: S0889-1591(14)00043-9. doi: 10.1016/j.bbi.2014.01.018. [Epub ahead of print]
45. Nguyen LT, Picard-Bernard V, Perriot J. Legionnaires disease in cannabis smokers.
Chest. 2010 Oct;138(4):989-91.
46. Benseñor IM, Cook NR, Lee IM, Chown MJ, Hennekens CH, Buring JE, Manson JE. Active and passive smoking and risk of colds in women. Ann Epidemiol. 2001 May;11(4):225-31.
47. Cordain L, Friel J. The Paleo Diet for Athletes (Revised). Rodale Press, Emmaus, PA, 2012.
48. Versteeg PA, Slot DE, van der Velden U, van der Weijden GA. Effect of cannabis usage on the oral environment: a review. Int J Dent Hyg. 2008 Nov;6(4):315-20.
49. Cho CM, Hirsch R, Johnstone S. General and oral health implications of cannabis use. Aust Dent J. 2005 Jun;50(2):70-4.
50. Jaques SC, Kingsbury A, Henshcke P, Chomchai C, Clews S, Falconer J, Abdel-Latif ME, Feller JM, Oei JL. Cannabis, the pregnant woman and her child: weeding out the myths. J Perinatol. 2014 Jan 23. doi: 10.1038/jp.2013.180. [Epub ahead of print]
51. Hayatbakhsh MR, Flenady VJ, Gibbons KS, Kingsbury AM, Hurrion E, Mamun AA, Najman JM. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res. 2012 Feb;71(2):215-9. doi: 10.1038/pr.2011.25. Epub 2011 Dec 21.
52. El Marroun H, Tiemeier H, Steegers EA, Jaddoe VW, Hofman A, Verhulst FC, van den Brink W, Huizink AC. Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. J Am Acad Child Adolesc Psychiatry. 2009 Dec;48(12):1173-81
53. Hurd YL, Wang X, Anderson V, Beck O, Minkoff H, Dow-Edwards D.
Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol Teratol. 2005 Mar-Apr;27(2):221-9
54. Varner MW, Silver RM, Rowland Hogue CJ, Willinger M et al. Association between stillbirth and illicit drug use and smoking during pregnancy. Obstet Gynecol. 2014 Jan;123(1): 113-25.
55. Bari M, Battista N, Pirazzi V, Maccarrone M.The manifold actions of endocannabinoids on female and male reproductive events. Front Biosci (Landmark Ed). 2011 Jan 1;16:498-516.
56. Park B, McPartland JM, Glass M. Cannabis, cannabinoids and reproduction. Prostaglandins Leukot Essent Fatty Acids. 2004 Feb;70(2):189-97
57. Whan LB, West MC, McClure N, Lewis SE. Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. Fertil Steril. 2006 Mar;85(3):653-60.
58. Horwood LJ, Fergusson DM, Hayatbakhsh MR, Najman JM, Coffey C, Patton GC, Silins E, Hutchinson DM. Cannabis use and educational achievement: findings from three Australasian cohort studies. Drug Alcohol Depend. 2010 Aug 1;110(3):247-53
59. Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addiction. 2008 Jun;103(6):969-76;
60. Fergusson DM, Horwood LJ, Beautrais AL. Cannabis and educational achievement.
Addiction. 2003 Dec;98(12):1681-92
61. Verweij KJ, Huizink AC, Agrawal A, Martin NG, Lynskey MT. Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability?
Drug Alcohol Depend. 2013 Dec 1;133(2):580-6
62. Grant JD, Scherrer JF, Lynskey MT, Agrawal A, Duncan AE, Haber JR, Heath AC, Bucholz KK. Associations of alcohol, nicotine, cannabis, and drug use/dependence with educational attainment: evidence from cotwin-control analyses. Alcohol Clin Exp Res. 2012 Aug;36(8):1412-20
63. Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction. 2000 Nov;95(11):1621-30.
64. Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004 Nov;53(11):1566-70.
65. Iacopetti CL1, Packer CD. Cannabinoid Hyperemesis Syndrome: A Case Report and Review of Pathophysiology. Clin Med Res. 2014 Mar 25. [Epub ahead of print]
66. Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc. 2012 Feb;87(2):114-9.
67. Hickey JL, Witsil JC, Mycyk MB. Haloperidol for treatment of cannabinoid hyperemesis syndrome. Am J Emerg Med. 2013 Jun;31(6):1003.e5-6
68. Nicolson SE, Denysenko L, Mulcare JL, Vito JP, Chabon B. Cannabinoid hyperemesis syndrome: a case series and review of previous reports. Psychosomatics. 2012 May-Jun;53(3):212-9.
What are the physiological ramifications of regular pot smoking or ingestion of marijuana upon your health and well being while following a Paleo Diet?